During the past decade, Linnan Klinikka conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Linnan Klinikka" #1 collaborator was "Linnan Klinikka Oy" with 3 trials as a collaborator, "Finnish Red Cross Blood Service" with 2 trials as a collaborator, "MTT Agrifood Research Finland" with 1 trials as a collaborator and "Mehiläinen Hämeenlinna, Finland" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Linnan Klinikka" are "Metabolic Syndrome" (3 trials), "Cardiovascular Disease" (2 trials) and "Coronary Heart Disease" (1 trials). Many other conditions were trialed in "Linnan Klinikka" in a lesser frequency.

Most popular intervention types in "Linnan Klinikka" are "Drug" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Cold-pressed turnip rapeseed oil (CTPRO)" (1 trials) and "milk fat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Linnan Klinikka" are 3 trials for "Male" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Linnan Klinikka". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Linnan Klinikka, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Linnan Klinikka, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".